Who owns LEXARIA BIOSCIENCE?
- Ticker: LEXX
- CUSIP Number: 52886n406
Tip: Access positions for across all investors
Analyze quarterly positions in Lexaria Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lexaria Bioscience stock
Who bought or sold LEXARIA BIOSCIENCE this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Invenomic Capital Management | 442k | $345k | -6% | Mar 2026 |
|
| Geode Capital Management | 294k | $230k | 34% | Mar 2026 |
|
| Vanguard Capital Management | 222k | $173k | 100% | Mar 2026 |
|
| Toronto-Dominion Bank | 140k | $851k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 94k | $73k | 100% | Mar 2026 |
|
| UBS Group | 53k | $41k | -85% | Mar 2026 |
|
| State Street Corporation | 39k | $31k | 0% | Mar 2026 |
|
| BlackRock | 27k | $21k | 0% | Mar 2026 |
|
| XTX Topco | 25k | $20k | 100% | Mar 2026 |
|
| Krilogy Financial | 24k | $14k | 23% | Jun 2026 |
|
| Vontobel Holding | 23k | $18k | 100% | Mar 2026 |
|
| Hrt Financial | 19k | $14k | 100% | Mar 2026 |
|
| Northern Trust | 18k | $14k | 0% | Mar 2026 |
|
| Renaissance Technologies | 16k | $13k | 4% | Mar 2026 |
|
| Bank Of Montreal | 14k | $11k | 100% | Mar 2026 |
|
| Citadel Advisors | 14k | $11k | 100% | Mar 2026 |
|
| Vanguard Global Advisers | 10k | $8.0k | 100% | Mar 2026 |
|
| BCV Asset Management | 10k | $7.8k | 100% | Mar 2026 |
|
| Royal Bank of Canada | 7.1k | $6.0k | 100% | Mar 2026 |
|
| Crews Bank & Trust | 3.9k | $2.2k | 100% | Jun 2026 |
|
| Advisor Group Holdings | 605.00 | $470.992500 | -72% | Mar 2026 |
|
| Citigroup | 489.00 | $380.979900 | 100% | Mar 2026 |
|
| Federation des caisses Desjardins du Quebec | 382.00 | $297.998200 | 0% | Mar 2026 |
|
| Farther Finance Advisors | 172.00 | $95.993200 | 4% | Jun 2026 |
|
| Gables Capital Management | 13.00 | $9.999600 | 0% | Mar 2026 |
|
| Morgan Stanley | 3.00 | $2.000100 | 0% | Mar 2026 |
|
| Tower Research Capital | 2.00 | $2.000000 | -94% | Mar 2026 |
|
| SBI Securities | 1.00 | $1.000000 | 100% | Mar 2026 |
|
Who sold out of Lexaria Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Byrne Asset Management | Mar 2026 | 800.00 | $624.000000 |
| MAI Wealth Advisors | Dec 2025 | 200.00 | $124.000000 |